WT mice subjected to DSS and subsequently treated with a STING agonist exhibit worsened colitis severity. STING-deficient mice subjected to DSS exhibit reduced colitis severity. M2 murine macrophages treated in vitro with a STING agonist repolarize into an M1-pro-inflammatory subtype. This evidence concerns the gene STING1 and colitis.